Discriminant factor analysis of 31p nmr spectroscopic data in myopathies
- 31 January 1990
- journal article
- research article
- Published by Wiley in Magnetic Resonance in Medicine
- Vol. 13 (2) , 216-227
- https://doi.org/10.1002/mrm.1910130205
Abstract
Discriminant factor analysis (DFA) enables one to distinguish among diagnostic groups using diagnostic variables. It provides discriminant functions that are linear combinations of the diagnostic variables and that optimally separate diagnostic groups. It was used to enhance the accuracy of 31P NMR data in the diagnosis of myopathies. DFA allowed a good separation of normal subjects, congenital neuromuscular disorders with type I fiber predominance, and McArdle's diseases. It elicited an unexpected homogeneity of idiopathic rhabdomyolyses, the metabolic origin of which is unknown, and suggested that the abnormality could involve the mitochondrial oxidative metabolism in some of them. In mitochondrial myopathies, an expected heterogeneity is shown by DFA. It may allow an automatic diagnosis of some myopathies from 31P NMR data or guide biochemists by comparing biochemical features of a new patient to those of previously established groups.This publication has 6 references indexed in Scilit:
- Phosphorus NMR spectroscopy study of muscular enzyme deficiencies involving glycogenolysis and glycolysisNeurology, 1987
- 31 P NMR studies in Duchenne muscular dystrophyNeurology, 1987
- Investigation of human mitochondrial myopathies by phosphorus magnetic resonance spectroscopyAnnals of Neurology, 1985
- Phosphorus nuclear magnetic resonance of fast- and slow-twitch muscleAmerican Journal of Physiology-Cell Physiology, 1985
- Examination of a Case of Suspected McArdle's Syndrome by31P Nuclear Magnetic ResonanceNew England Journal of Medicine, 1981
- Dynamic properties of mammalian skeletal muscles.Physiological Reviews, 1972